A detailed history of Strategic Financial Services, Inc, transactions in Novo Nordisk A S stock. As of the latest transaction made, Strategic Financial Services, Inc, holds 2,399 shares of NVO stock, worth $252,038. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,399
Previous 2,399 -0.0%
Holding current value
$252,038
Previous $342,000 16.67%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $12,639 - $15,131
-103 Reduced 4.12%
2,399 $342,000
Q3 2023

Nov 06, 2023

BUY
$90.94 - $199.54 $227,531 - $499,249
2,502 New
2,502 $227,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Strategic Financial Services, Inc, Portfolio

Follow Strategic Financial Services, Inc, and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Financial Services, Inc,, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Financial Services, Inc, with notifications on news.